| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |